Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing esomeprazole, amoxicillin, and clarithromycin. It is designed for the eradication of *Helicobacter pylori* (*H. pylori*). Esomeprazole is a proton pump inhibitor (PPI), amoxicillin is a penicillin-class antibiotic, and clarithromycin is a macrolide antibiotic.
## Primary Indications
Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
The standard adult dose is one Sompraz HP pack taken twice daily for 7 days. Each pack typically contains:
* Esomeprazole 20 mg
* Amoxicillin 500 mg
* Clarithromycin 500 mg
**Important:** The specific contents of "Sompraz HP" may vary by region or manufacturer. Always verify the exact dosage and components of the prescribed product. Dosing and duration are often guided by local eradication protocols.
## Pediatric Dosing
The use of this specific combination product in pediatrics is not well-established. Dosing for pediatric *H. pylori* eradication is typically individualized based on age, weight, and local resistance patterns, often using separate components rather than fixed-dose combinations. Consult pediatric infectious disease or gastroenterology guidelines.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is typically required for esomeprazole, amoxicillin, or clarithromycin within standard treatment durations for mild to moderate renal impairment. Severe renal impairment may warrant caution, particularly with amoxicillin and clarithromycin, but specific dose reductions for this combination are not universally defined.
* **Hepatic Impairment:** No dose adjustment is generally recommended for amoxicillin or clarithromycin in mild to moderate hepatic impairment. Esomeprazole dose reduction may be considered in severe hepatic impairment, but specific guidance for the combination is lacking.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, other macrolides, penicillins, or any component of the formulation.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Severe renal impairment (especially relevant for amoxicillin and clarithromycin dosing considerations).
* Concurrent use with certain drugs, such as cisapride, pimozide, and ergot alkaloids (due to clarithromycin).
## Adverse Effects
Common adverse effects include:
* **GI:** Diarrhea, nausea, vomiting, abdominal pain, taste perversion (metallic taste with clarithromycin).
* **Other:** Headache, rash, yeast infections.
* **Serious:** *Clostridium difficile*-associated diarrhea, severe hypersensitivity reactions (including anaphylaxis), Stevens-Johnson syndrome/toxic epidermal necrolysis, QT prolongation (clarithromycin), hepatotoxicity.
## Key Drug Interactions
* **Clarithromycin:** Potent inhibitor of CYP3A4. Avoid co-administration with cisapride, pimozide, certain statins, and ergot alkaloids. May increase levels of numerous other drugs (e.g., warfarin, cyclosporine, tacrolimus, certain benzodiazepines).
* **Esomeprazole:** Inhibits CYP2C19 and CYP3A4. May affect absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, certain HIV medications). May increase levels of drugs metabolized by CYP2C19 (e.g., clopidogrel - though clinical significance with fixed-dose combination is complex).
* **Amoxicillin:** May decrease the effectiveness of oral contraceptives. Probenecid may decrease renal excretion of amoxicillin.
## Monitoring
* **Clinical Response:** Assess for resolution of ulcer symptoms and signs of *H. pylori* eradication. Urea breath test or stool antigen test is typically performed 4-8 weeks after completion of therapy to confirm eradication.
* **Adverse Events:** Monitor for diarrhea, rash, signs of hypersensitivity, and liver function if clinically indicated.
* **Drug Interactions:** Review concomitant medications for potential interactions, especially with clarithromycin.
## Clinical Pearls
* This is a triple therapy regimen; adherence is critical for successful *H. pylori* eradication.
* Administer esomeprazole 20 mg at least 30 minutes before meals. The amoxicillin and clarithromycin components should be taken with meals to minimize GI upset.
* Educate patients on the importance of completing the full course of therapy, even if they feel better.
* Consider local *H. pylori* resistance patterns when selecting empiric therapy.
***
**Disclaimer:** This information is intended for clinical use and is not a substitute for professional medical advice. Always consult the most current prescribing information, product monographs, and relevant clinical guidelines before making any treatment decisions. Local protocols and formularies may influence drug selection and dosing.